No abstract available
Publication types
-
Editorial
-
Research Support, Non-U.S. Gov't
-
Comment
MeSH terms
-
Adalimumab
-
Anti-Inflammatory Agents, Non-Steroidal / economics
-
Anti-Inflammatory Agents, Non-Steroidal / standards
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
-
Antibodies, Monoclonal / economics*
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Canada
-
Cost-Benefit Analysis
-
Etanercept
-
Humans
-
Immunoglobulin G / economics*
-
Immunoglobulin G / therapeutic use*
-
Quality of Life
-
Receptors, Tumor Necrosis Factor / therapeutic use*
-
Spondylitis, Ankylosing / drug therapy*
-
Spondylitis, Ankylosing / economics*
-
State Medicine
-
United Kingdom
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Immunoglobulin G
-
Receptors, Tumor Necrosis Factor
-
Adalimumab
-
Etanercept